Alternatives to Mammoth Biosciences

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Hacking healthcare with CRISPR technology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Scalable, one-time curative in-vivo gene editing therapies.

AI-enabled technology for cell biology research and biopharma development.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered knowledge discovery for life sciences.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

Developing novel therapies to reverse aging and extend lifespan.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Develops and distributes bioreactor technology for stem cell cultivation.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Platform designed to cut cell and gene therapy production costs.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing disease-responsive advanced therapies through programmable gene control technology.

Developing human microbiology models for drug discovery.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Developing an automated platform for liquid biopsy sample preparation.

AI-driven predictive modeling company focused on biology and life sciences.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Building General Biological Intelligence

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.